The present invention is directed to novel codrugs comprising bupropion or hydroxybupropion and an opioid antagonist or an opioid agonist joined together by chemical bonding. The codrugs provide a significant increase in the transdermal flux across human skin, as compared to the basic opioid antagonist or opioid agonist.

 
Web www.patentalert.com

< Nanoscale manganese oxide on ultraporous carbon nanoarchitecture

> Carbon Black Coloring Agent for Semiconductor Sealing Material and Method of Manufacturing the Same

~ 00490